Stericycle Inc. (NASDAQ:SRCL) – Oppenheimer Holdings lowered their FY2017 earnings per share (EPS) estimates for Stericycle in a research report issued on Monday. Oppenheimer Holdings analyst S. Schneeberger now expects that the brokerage will post earnings per share of $4.78 for the year, down from their prior forecast of $5.20.

Several other research analysts also recently commented on SRCL. Imperial Capital cut their target price on Stericycle from $100.00 to $95.00 and set an “in-line” rating on the stock in a report on Thursday, May 26th. Royal Bank Of Canada reaffirmed a “sell” rating on shares of Stericycle in a report on Thursday, May 26th. Zacks Investment Research downgraded Stericycle from a “hold” rating to a “sell” rating in a report on Tuesday, June 28th. Jefferies Group reissued a “buy” rating and issued a $140.00 price objective on shares of Stericycle in a research note on Monday, July 18th. Finally, Wellington Shields downgraded Stericycle from an “accumulate” rating to a “hold” rating in a research note on Friday, July 29th. Four research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $108.95.

Stericycle (NASDAQ:SRCL) traded up 0.32% on Tuesday, hitting $78.25. The company had a trading volume of 199,248 shares. Stericycle has a one year low of $76.76 and a one year high of $151.57. The stock’s 50-day moving average price is $84.48 and its 200 day moving average price is $102.42. The company has a market capitalization of $6.65 billion, a P/E ratio of 27.54 and a beta of 0.27.

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings data on Thursday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $1.18. The business earned $891.60 million during the quarter, compared to the consensus estimate of $910.29 million. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. Stericycle’s quarterly revenue was up 24.6% on a year-over-year basis. During the same period last year, the company earned $1.14 earnings per share.

In other news, EVP John P. Schetz sold 1,398 shares of the company’s stock in a transaction that occurred on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total value of $114,426.30. Following the completion of the transaction, the executive vice president now directly owns 1,088 shares of the company’s stock, valued at $89,052.80. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Mark C. Miller sold 24,665 shares of the company’s stock in a transaction that occurred on Friday, July 1st. The shares were sold at an average price of $104.55, for a total value of $2,578,725.75. Following the completion of the transaction, the director now directly owns 229,449 shares of the company’s stock, valued at $23,988,892.95. The disclosure for this sale can be found here. Company insiders own 3.30% of the company’s stock.

Several institutional investors have recently added to or reduced their stakes in SRCL. Norges Bank acquired a new position in Stericycle during the fourth quarter valued at about $76,432,000. Chevy Chase Trust Holdings Inc. raised its position in Stericycle by 5.2% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 74,656 shares of the company’s stock valued at $9,421,000 after buying an additional 3,659 shares in the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund raised its position in Stericycle by 15.6% in the first quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 16,521 shares of the company’s stock valued at $2,085,000 after buying an additional 2,227 shares in the last quarter. Exxonmobil Investment Management Inc. TX raised its position in Stericycle by 8.6% in the first quarter. Exxonmobil Investment Management Inc. TX now owns 20,692 shares of the company’s stock valued at $2,611,000 after buying an additional 1,643 shares in the last quarter. Finally, GW&K Investment Management LLC raised its position in Stericycle by 26.1% in the first quarter. GW&K Investment Management LLC now owns 74,373 shares of the company’s stock valued at $9,385,000 after buying an additional 15,402 shares in the last quarter. 92.80% of the stock is owned by institutional investors.

About Stericycle

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

5 Day Chart for NASDAQ:SRCL

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.